This major advance followed closely on the heels of the discovery that an activity in lymphocyte supernatants that inhibited HIV replication consisted of three chemo-
cytoplasmic domain sequences in CCR5. However, there is evidence that binding of envelope glycoprotein to the receptors can mimic binding of chemokines, resulting in activation of the heterotrimeric G proteins, Ca 2ϩ fluxing, and tyrosine phosphorylation (Davis et al., 1997; Weissman et al., 1997) . Such signals may have important roles in postentry events in retroviral replication and may also have pathogenic consequences in uninfected cells (see below). It is not yet known whether CD4 and the chemokine receptors normally interact in the plane of the membrane and if such complexes have specific signaling properties following binding of gp120. 
Chemokine Receptors in Transmission

and Disease Progression
Previous nomenclature for viral tropism is noted at the bottom. Macrophage-tropic viruses were also named NSI (non-syncytiumExamination of the phenotypes of HIV strains sampled inducing in T cell lines), whereas T cell line-tropic viruses were at different times in the course of infection showed that named SI (syncytium-inducing). These viruses are now named R5
isolates present during the early acute phase were macand X4, respectively. rophage-tropic, now known to be CCR5-specific. The significance of this finding was magnified by the startling with CD4 is nevertheless required to activate its fusodiscovery that a homozygous 32 bp deletion in the CCR5 genic potential. There are rare examples, however, in gene, found in about 1% of Caucasians, confers resiswhich CD4 is not even required for primate lentiviral tance to acquisition of HIV infection (reviewed in Stewentry. A strain of HIV-2 selected for growth in CD4
Ϫ cells art, 1998). Viral strains with X4 or R5X4 tropism usually was found to infect by utilizing CXCR4 alone (Endres et arise only later in the course of infection and are prevaal., 1996) , as was a spontaneously arising mutant HIV-1, lent during progression to disease. A major unanswered in which the phenotype was conferred by seven mutaquestion is why X4 strains are rarely, if ever, transmitted tions in gp120, including some in the V3 domain (Dubetween individuals. Rare CCR5⌬32 homozygotes have monceaux et al., 1998, and references therein). In addibeen reported among those infected, but it is unclear tion, several strains of neurovirulent SIV can infect CD4 Ϫ if they had acquired virus by way of CXCR4. During cells through CCR5 (see below), and SIV gp120 can progression of immunodeficiency and neurological disinteract with rhesus CCR5 in the absence of CD4. The ease, there is a general broadening of virus tropism, envelope glycoproteins of these viruses may already be with a variable degree of usage of additional chemokine in a fusion-competent conformation that only requires receptors or orphan GPCRs (see Table 1 ), and these interaction with the chemokine receptor for initiation of or other molecules yet to be defined may have been gp41-mediated fusion of lipid bilayers (reviewed by exploited in place of CCR5 during transmission. As Chan and Kim, 1998 [this issue of Cell]) . noted above, in contrast to CCR5-tropic viruses, X4 These results indicate that the chemokine receptor is strains cannot replicate in macrophages. It is possible the primary receptor that both binds envelope glycoprothat for HIV to evade early immune surveillance, particutein and triggers fusion. CD4 plays important roles, both larly by cytotoxic T cells, it needs to replicate in macroto concentrate virus at the surface of the cell (through phages or dendritic cells before spreading to T lymphohigh-affinity interaction with gp120) and to facilitate the cytes. Even if this is a requirement for establishment of subsequent essential interaction with the chemokine infection, it is surprising that alternate tropisms are so receptor. However, in contrast to the CD4-independent heavily disfavored in transmission, particularly when one entry described above, there is no example of infection considers the adaptability that HIV displays in its evoluthat is independent of GPCRs. Because the interaction tion in vivo to expanded receptor tropism. This observaof gp120 with CD4 was the first to be discovered, the tion suggests that CCR5 is expressed in a key population chemokine receptors are now commonly referred to as of cells, in which other GPCR family members that could HIV "coreceptors." It may be more appropriate to conpotentially be used by HIV are absent; or that CCR5 is sider CD4 as the rightful coreceptor, just as it is a coreendowed with unique biological properties, such as the ceptor in T cell antigen receptor-mediated signaling.
ability to transduce signals that may enhance viral repliNumerous studies have mapped regions of chemocation. It is also possible that expression of the CXCR4 kine receptors required for their HIV or SIV receptor ligand, SDF-1, in the lymphoid stroma inhibits transmisfunction (reviewed in Bieniasz and Cullen, 1998) . The sion of X4 strains. general consensus is that sequences in multiple regions Neurological Disease. A significant proportion of HIVof the receptors, including the N terminus and the extrainfected patients develop neurological disease, but the cellular loops, contribute to the interaction with envepathogenic mechanism remains obscure. For example, lope glycoproteins. Moreover, viruses appear to have it is not known whether neuronal cell death is due to evolved to be flexible in these interactions, since diverse direct infection of these cells or to indirect effects secstrains differ in their relative dependence on receptor ondary to interaction of neurons with viral or cellular domains. Coupling of the receptors to the heterotrimeric products released by infected cells. The cells thought G proteins appears to be dispensable for the process to transport the virus into the CNS are the monocyteof viral entry, as shown both through the use of pertussis derived microglial cells, which express CD4 as well as CCR5 and CCR3. These chemokine receptors have been toxin blockade and through mutagenesis of the relevant The "major" receptors have all been tested in viral infectivity assays with multiple strains. Some of the "minor" receptors have been tested mainly in cell fusion assays, which may not always be representative of viral infectivity.
proposed to be important for infection of microglial cells signals that dictate postfusion events in the retroviral replication cycle. It remains to be determined whether and, presumbably, for the development of AIDS dementhe observations with the different strains of SIV are due tia, although evidence also points to the possible use to differences in gp120 interaction with CCR5 or with of yet another receptor expressed on these cells (He et other macrophage surface molecules, possibly other al., 1997). There is also strong evidence that some HIV-1 members of the chemokine receptor family. and SIV strains can infect brain capillary endothelial cells Genetic Factors in Disease Progression through a CD4-independent mechanism which, for SIV The discovery of resistance to infection conferred by entry, involves CCR5 (Edinger et al., 1997). These results the homozygous CCR5⌬32 mutation has spurred further suggest an alternate route for dissemination of neuropagenetic studies to determine if mutations in chemokines thogenic strains to the central nervous system and also or their receptors may influence transmission and proraise the possibility that HIV envelope glycoproteins may gression to immunodeficiency (Stewart, 1998, and referinteract directly with chemokine receptors in the brain. ences therein). Heterozygosity for the CCR5⌬32 mutaSuch CD4-independent interactions may influence sigtion has been shown to delay progression to disease, naling pathways and may thus explain previous obseras have mutations in two other genes, CCR2 and SDF-1. vations that soluble gp120 is neurotoxic in cell culture
The benefit conferred by the heterozygous deletion in and in transgenic mice. Because several chemokine re-CCR5 is thought to result from decreased expression ceptors, including CXCR4, are expressed in the brain, it levels of the receptor in these patients. The effect of will be important to determine the full spectrum of recepthe mutation in the CCR2 gene is not yet understood, tor specificities of neuropathogenic strains of HIV-1.
particularly because the mutation is in a transmembrane Receptors in Nonhuman Primates. The SIV disease region and does not affect HIV entry, and because the model in the Rhesus macaque is currently the best anigene product is used only by a small fraction of viruses. mal model for HIV disease in humans. In both diseases, However, the CCR2 gene is closely linked to CCR-5, infection results in immunodeficiency and neurodegenand a strong linkage disequilibrium has been reported erative disease, and the time to disease onset correlates for the mutation and a polymorphism in the CCR5 regulainversely with the level of plasma viremia during the tory region. It is therefore possible that the CCR2 mutaasymptomatic phase. In contrast to HIV-1 strains, which tion is also associated with lower levels of CCR5 exprespredominantly utilize CCR5, CXCR4, or both, SIVs do sion. The effect of the mutation in the gene encoding not use CXCR4. However, most strains of SIV and many SDF-1, the only known ligand of CXCR4, is the most of HIV-2 utilize two orphan GPCRs, Bonzo/STRL33/ difficult to understand. It has been proposed that this TYMSTR and BOB/GPR15, as efficiently as CCR5 (Deng mutation in the 3Ј untranslated region of one of the two et al., 1997). Evolution of receptor tropism in the SIV SDF-1 alternatively spliced isoforms results in a higher model is not yet well-characterized, and it is unclear if level of chemokine, which may limit infection with X4 transmission and progression to disease are dependent strains in vivo, but this has yet to be substantiated. on CCR5 or the other receptors.
The protective effect has only been clearly observed in Studies with SIV offer potentially valuable insight into individuals homozygous for the SDF-1 polymorphism. the role of envelope-receptor interactions in postentry Chemokine Receptors as Potential events in macrophages. CCR5-specific strains that difTherapeutic Targets fer only in their gp120 sequence differ in their abilities
The finding that chemokines can inhibit HIV replication to replicate in macaque macrophages, even though they by blocking viral entry has provided the impetus to decan undergo envelope-mediated fusion equally well velop compounds that will interfere with HIV binding to (Mori et al., 1993) . HIV-1 strains with CCR5 tropism that CCR5 and CXCR4. Because the absence of CCR5 does replicate in primary activated T cells but not in macronot appear to result in a significant phenotype, blocking phages have also been described, although it is unclear of CCR5 function with specific agents is likely to be well if these can also enter the nonpermissive cells. Interactolerated. There is, however, the concern that interfertion of the envelope glycoproteins with structures on ence with viral utilization of CCR5 may accelerate selection of strains with broader tropism that could potentially the macrophage cell surface may thus potentially initiate Doranz, B.J., Grovit-Ferbas, K., Sharron, M.P., Mao, S.H., Goetz, be more pathogenic. This concern is mitigated to some M.B., Daar, E.S., Doms, R.W., and O'Brien, W.A. (1997). J. Exp. Med.
degree by the observed delay in disease progression in 186, 1395-1400. individuals heterozygous for the CCR5⌬32 allele.
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response to chemokine (Heveker et al., 1998 block viral entry without affecting the physiological function of the receptor.
Future Prospects
Despite the important advances made in studies of chemokine receptor family members in HIV and SIV entry, much remains to be learned of the potential roles of these receptors in transmission and disease progression. It will be important to learn if pathogenesis directly involves the known receptors or perhaps even additional receptors yet to be identified. The normal functions of such receptors will need to be fully understood, and this will likely require studies in gene-targeted mice. It is also unclear if individual receptors have signal-transducing properties that can be exploited by different viruses. A combination of studies on the biology of virus replication in different primary cells and on animal model systems will be required to address these questions.
